Showing results (61-70 of 100) with videos related to
Sort By:
Pageof 10
Tropical Medicine & International Health : TM & IH|November 13, 2001
Drugs for neglected diseases: a failure of the market and a public health failure?P Trouiller, E Torreele, P Olliaro, et al.The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|February 13, 2007
An in vivo test to assess mefloquine 25 mg/kg for the treatment of uncomplicated falciparum malaria in Rondônia, BrazilS A Basano, A Bianco, W R J Taylor, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|May 1, 1996
Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding studyC P Thakur, A K Pandey, G P Sinha, et al.Experimental Parasitology|February 13, 2001
Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugsS Parapini, N Basilico, E Pasini, et al.Journal of Chemotherapy (Florence, Italy)|April 1, 1996
Rifabutin as salvage therapy for cases of chronic multidrug-resistant pulmonary tuberculosis in TaiwanC N Lee, T P Lin, M F Chang, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|August 6, 1998
The effect of synthetic malaria pigment (beta-haematin) on adhesion molecule expression and interleukin-6 production by human endothelial cellsD Taramelli, N Basilico, A M De Palma, et al.Parassitologia|June 25, 2002
Ultrastructural characteristics, biological activity and pharmacological relevance of synthetic malaria pigment (beta-haematin)D Taramelli, D Monti, F Omodeo-Salè, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1994
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondiiP Olliaro, G Gorini, D Jabes, et al.Acta Tropica|August 26, 1998
Response of uncomplicated falciparum malaria to oral chloroquine and quinine in Burundi highlandsG Di Perri, P Olliaro, S Nardi, et al.American Journal of Respiratory and Critical Care Medicine|November 1, 1996
Efficacy and safety of rifabutin in the treatment of patients with newly diagnosed pulmonary tuberculosisM M McGregor, P Olliaro, L Wolmarans, et al.Pageof 10